Education
About Us
Working with TipRanks
Follow Us
Satellos Bioscience (MSLE)
NASDAQ:MSLE
MSLE Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MSLE Stock 12 Month Forecast
Average Price Target
$8.44
▼(-25.04% Downside)
| Highest Price Target$16.00 | Average Price Target$8.44 | Lowest Price Target$0.88 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Leede Financial
$27→$16
Buy
42.10%
Upside
Reiterated
02/11/26
This Canadian biotech stock is undervalued, analyst saysLoe said recent capital structure adjustments have minimal bearing on our investment thesis for the firms lead drug SAT-3247, while materially strengthening the balance sheet and reducing financial risk. Satellos recently completed a 12-for-1 share consolidation, followed by a US$50-million equity offering, which Loe said meaningfully improves the companys ability to fund ongoing Phase II and future Phase III clinical development.
H.C. Wainwright
$0.88
Buy
-92.19%
Downside
Reiterated
11/21/25
Canaccord Genuity
$0.92
Buy
-91.87%
Downside
Reiterated
05/23/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leede Financial
$27→$16
Buy
42.10%
Upside
Reiterated
02/11/26
This Canadian biotech stock is undervalued, analyst saysLoe said recent capital structure adjustments have minimal bearing on our investment thesis for the firms lead drug SAT-3247, while materially strengthening the balance sheet and reducing financial risk. Satellos recently completed a 12-for-1 share consolidation, followed by a US$50-million equity offering, which Loe said meaningfully improves the companys ability to fund ongoing Phase II and future Phase III clinical development.
H.C. Wainwright
$0.88
Buy
-92.19%
Downside
Reiterated
11/21/25
Canaccord Genuity
$0.92
Buy
-91.87%
Downside
Reiterated
05/23/25
Best Analysts Covering Satellos Bioscience
3 Months
xxx
Success Rate
7/10 ratings generated profit
Average Return
+26.65%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +26.65% per trade.
1 Year
Success Rate
9/10 ratings generated profit
Average Return
+46.32%
reiterated a buy rating 3 months ago
Copying Arthur He CFA's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +46.32% per trade.
2 Years
xxx
Success Rate
10/10 ratings generated profit
Average Return
+111.67%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +111.67% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MSLE Analyst Recommendation Trends
Rating
Sep 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
0
Buy
3
3
2
2
2
Hold
0
0
1
32
50
Sell
0
0
0
0
0
Strong Sell
0
0
0
5
5
total
3
3
3
39
57
Each month's total comprises the sum of three months' worth of ratings.
MSLE Financial Forecast
MSLE Stock Forecast FAQ
What is MSLE’s average 12-month price target, according to analysts?
Based on analyst ratings, Satellos Bioscience’s 12-month average price target is 8.44.
What is MSLE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MSLE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MSLE a Buy, Sell or Hold?
Satellos Bioscience has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Satellos Bioscience’s price target?
The average price target for Satellos Bioscience is 8.44. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $16.00 ,the lowest forecast is $0.88. The average price target represents -25.04% Decrease from the current price of $11.26.
The highest analyst price target is $16.00 ,the lowest forecast is $0.88. The average price target represents -25.04% Decrease from the current price of $11.26.
What do analysts say about Satellos Bioscience?
Satellos Bioscience’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of MSLE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.